Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Target Price at $26.60
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective […]
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective […]
